Joyita Dutta

Has grant

Professor

University of Massachusetts Amherst
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Genomics-guided sleep biomarker discovery for early Alzheimer's disease: A wearables study

Open Date: 2024-07-01

Close Date: 2029-04-30

Grant: Close

Super-Resolved Multimodal Imaging Biomarkers for Frontotemporal Dementia

Open Date: 2024-06-15

Close Date: 2026-03-31

Grant: Close

Early Alzheimers Forecasting from Multimodal Data via Deep Transfer Learning, Evaluated on a Large-Scale Prospective Cohort Study

Open Date: 2023-09-01

Close Date: 2025-08-31

Grant: Close

Longitudinal predictive modeling for tau in Alzheimer's disease

Open Date: 2021-09-01

Close Date: 2026-05-31

Grant: Close

Super-Resolution Tau PET Imaging for Alzheimer's Disease

Open Date: 2021-01-15

Close Date: 2024-12-31

Articles (20)

Year:

2026

Year:

2026

Alzheimer’s disease (AD) is the most common cause of dementia and a significant public health challenge. AD is characterized by the formation of tau and beta-amyloid (Aβ) protein aggregates in the brain, which can be imaged in vivo using positron emission tomography (PET). Integrating genetic and neuroimaging data using imaging genetics tools offers the potential to better understand disease mechanisms and risk factors in this heterogeneous disorder. Here, we present a framework based on Sparse Canonical Correlation Analysis (SCCA) integrated with clustering to identify AD subtypes from PET and genomic data. The SCCA clustering method was applied to tau PET scans (N = 541), Aβ PET scans (N = 907), and corresponding genomics data from the Alzheimer’s Disease Neuroimaging Initiative database. Test-retest studies were used to compare two different SCCA implementations, and longitudinal data were used to assess the stability of the subtyping approach. We identified four tau subtypes and two Aβ subtypes with distinct spatial deposition patterns, consistent with prior imaging studies. Genetic profiles associated with each subtype showed enrichment of specific biological pathways. Our findings suggest that SCCA clustering can help reveal biologically meaningful subtypes of AD. A clearer understanding of AD subtypes could ultimately improve AD diagnosis, prognosis, and treatment strategies.

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background While cortical atrophy has been widely studied in dementia, emerging evidence highlights the role of subcortical degeneration, particularly in deep gray matter structures such as the thalamus, claustrum, and basal nuclei, in both Alzheimer's disease (AD) and frontotemporal dementia (FTD). However, disease-specific subcortical patterns remain undercharacterized. Objective To quantify deep gray matter atrophy across the AD continuum (mild cognitive impairment and AD) and three FTD subtypes (bvFTD, svFTD, PNFA), and to assess longitudinal atrophy, cognitive associations, and diagnostic classification. Methods We applied a novel segmentation pipeline (sTHOMAS) to T1-weighted MRI data from 380 participants in the ADNI cohort and 274 participants in the FTLDNI cohort, with longitudinal follow-up available for 237 participants. Group differences were assessed using ANCOVA (adjusted for age and sex), followed by post hoc comparisons and effect size estimation (Cohen's d). Neuropsychological associations were examined using partial correlations. A hierarchical Random Forest model was trained to classify diagnostic groups. Results Pronounced atrophy was observed in the mediodorsal, anteroventral, pulvinar thalamic nuclei, and nucleus accumbens, and claustrum in both AD and FTD, but was significantly greater in bvFTD. Longitudinal analysis revealed the fastest progression in bvFTD. Classification achieved 96.8% accuracy (AUC = 0.99) for AD versus FTD and 77.7% accuracy (AUC = 0.83) for PNFA versus svFTD. Subcortical atrophy correlated to executive, language, and semantic deficits. Conclusions Atrophy in the mediodorsal, pulvinar, anteroventral thalamic nuclei, nucleus accumbens, and claustrum distinguishes AD from FTD and differentiates FTD subtypes. These subcortical structures represent promising biomarkers for diagnosis and monitoring of neurodegeneration.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Alberto Cacciola

Humanitas University

ITALY
View details

Michael Hornberger

Professor of Applied Dementia Research

University of Southampton

UNITED KINGDOM
View details

Nicolas Karakatsanis

Associate Professor of Biomedical Engineering

Weill Cornell Medical College

UNITED STATES
View details

Guido Davidzon

Stanford University

UNITED STATES
View details

Alejandro Bertolet

Assistant Professor

Massachusetts General Hospital

UNITED STATES
View details

Steven R. Meikle

Head of Imaging Physics Lab

University of Sydney

AUSTRALIA
View details

Manoj Saranathan

Professor

-

UNITED STATES
View details

Irene Buvat

CNRS Délégation Ile-de-France Sud

FRANCE
View details

Kuangyu Shi

Head of Lab for Artificial Intelligence & Translational Theranostics

University of Bern

SWITZERLAND
View details

Quanzheng Li

Massachusetts General Hospital

UNITED STATES
View details